SOHM received confirmed orders for OTC products
Mr. Shailesh Shah, President and CEO, today states that SOHM received a boost in its restructuring process when the buyer confirmed committed orders for minimum $ 300,000 and
Mr. Shailesh Shah, President and CEO, today states that SOHM received a boost in its restructuring process when the buyer confirmed committed orders for minimum $ 300,000 and
Inhalation of a non-sterile product with microbial contamination into the airways could increase the risk of respiratory infection. The risk is higher in patients who are immunocompromised (because
Tekmira today reported that: Enrolment of the target patient numbers in these Phase I/II studies has been completed; To date, 55 patients, in the both the Phase I
This study assesses a drug’s risk of QT prolongation and its proarrhythmic potential, and is a standard component of all clinical development programs for new molecular entities. Pyridorin
HPP is a genetic, chronic and progressive ultra-rare metabolic disease that can lead to destruction and deformity of bones, profound muscle weakness, seizures, respiratory failure and premature death.1-5
These countries include Bulgaria, the Czech Republic, Hungary, Poland, Romania, Slovakia and Slovenia. With this distributorship in place, Iclusig will be available to patients with resistant and intolerant
The approval was based by data from over 2,700 subjects treated with peramivir in 27 clinical trials. University of Alabama Dr Richard Whitley said: "RAPIVAB is the first
This patent includes AC-201 or its pharmaceutically acceptable salts, active metabolite for treatment of type II diabetes. The patent also covers the methods of treatment using AC-201 for
"This is the second jurisdiction in which we have elected to file for Orphan Designation," said Dr. Brad Thompson , President and CEO of Oncolytics. "The EMA serves
EpiVax and Novozymes Biopharma today announced that they have entered a license agreement for the development of novel treatments for autoimmune diseases. The agreement follows two years of